The mechanism by which PD-1/PD-L1 acts to inhibit the cytotoxic activity of CD8 T cells is via the inhibitory cell signaling triggered by PD-L1 on the tumor and the inhibitory PD-1 receptor on the CD8 T cells. The gene discussed is CD8A; the disease is neoplasm.